Recently, accumulated evidence showed that in HBV-related hepatocellular carcinoma or viral infections, beta-actin and GAPDH are unsuitable controls in quantitative mRNA expression or Western blot analysis due to variations in expression [56-60], though there are controversial observations [61]. The gene discussed is GAPDH; the disease is hepatocellular carcinoma.